期刊文献+

积大本特治疗Ⅱ度良性前列腺增生症35例的效果观察

下载PDF
导出
摘要 目的:观察积大本特(盐酸坦洛新缓释片)对Ⅱ度良性前列腺增生症的治疗效果。方法:选择35例前列腺Ⅱ度良性增生的患者,给予口服积大本特片0.2mg,每晚1次,连服4周。对比治疗前后患者的国际前列腺症状评分(IPSS)、最大尿流率(MFR)、平均尿流率(AFR)、残余尿量(Ru)、前列腺体积、血压等变化情况。结果:经过治疗,患者的IPSS评分及残余尿量明显下降(P<0.01),而MFR与AFR均明显增加,差异有统计学意义(P<0.01)。前列腺体积及血压治疗前后比较差异无统计学意义(P>0.05)。结论:积大本特能改善Ⅱ度良性前列腺增生症的症状、提高患者的生活质量,具有良好的临床实用价值。
作者 蔡文
出处 《中国社区医师(医学专业)》 2011年第25期89-89,共1页
  • 相关文献

参考文献4

  • 1Micheal MC, Neumann HG, Mehlburger, et al. Doesthe time of administration (morning or evening) affect the tolerabilityor efficacy of ta- msulosin[ J]. Int,2001,87 ( 1 ) :31 - 35.
  • 2Price D T, Schw NN D A, Lomasney J W, et al. Identification, quantification and localliza- tion of mRNA for three distinct alpha 1 adren- ergic receptor subtypes in human prostate [J]. J Urol,2003,150(2Pt1 ) :546 -551.
  • 3Narayan P, Lepor H. Long term, open - label, phase Ill multicenterstudy of tamsulsin in be- nign prostatic hyperplasia [ J ]. U - rology, 2001,57:466 - 467.
  • 4叶璐,任宇,李懿,宋豪,李宁宁,初铮铮,熊鹰.特拉唑嗪、坦洛新及非那雄胺治疗良性前列腺增生症的安全性评价[J].药物不良反应杂志,2005,7(6):411-417. 被引量:15

二级参考文献16

  • 1熊鹰,叶璐,任宇,李懿,宋豪,李宁宁,初铮铮,李幼平.特拉唑嗪、非那司提和坦素罗辛治疗良性前列腺增生症的有效性评价[J].中国循证医学杂志,2005,5(6):448-454. 被引量:10
  • 2那彦群,汪迪,金杰,郭应禄,薛兆英,顾方六.选择性α_(1a)受体阻断剂治疗前列腺增生症[J].中华泌尿外科杂志,1996,17(6):327-329. 被引量:22
  • 3Clifford GM, Richard DT. Drug or symptom-induced depression in men treated with alphal-blockers for benign prostatic hyperplasia? A nested case-control study[J]. Pharmacoepidemiol Drug Saf, 2002, 11:55.
  • 4Michel MC, Neumann HG, Mehlburger L, et al. Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin [J]? BJU Int,2001, 87(1):31.
  • 5Mann RD, Biswas P, Freemantle S, et al. The pharmacovigilance of tamsulosin: event data on 12 484 patients[J]. BJU Int, 2000, 85(4):446.
  • 6Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age [J]. J Urol, 1984, 132:474.
  • 7Okada H, Kamidono S, Yoshioka T, et al. A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hypcrplasia in Japanese patients[J]. BJU International,2000, 85(6):676.
  • 8Lee E. Clinical comparison of selective and non-selective ala-adrenoreceptor antagonists in benign prostatic hyperplasia:studies on tamsulosin in a fixed dose and terazosin inincreasing doses[J]. Br J Urol, 1997, 80:606.
  • 9Tsujii T. Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia[J]. Int J Urol, 2000, 7(6): 199.
  • 10de Mey C, Michel, Mc Ewen J, et al. A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing[J]. Eur Urol, 1998,33:481.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部